Thiazide Diuretics (e.g., Hydrochlorothiazide, Chlorthalidone) |
- Hypokalemia (low potassium)
- Hyponatremia (low sodium)
- Hypercalcemia (high calcium)
- Hyperuricemia (may trigger gout)
- Hyperglycemia (may affect blood sugar levels)
|
- NSAIDs: May reduce diuretic effectiveness.
- Digoxin: Risk of toxicity with hypokalemia.
- Lithium: Increases lithium levels, risk of toxicity.
- ACE Inhibitors/ARBs: Combined use increases risk of hypotension.
|
Loop Diuretics (e.g., Furosemide, Bumetanide) |
- Hypokalemia
- Hypomagnesemia (low magnesium)
- Hypocalcemia (low calcium)
- Dehydration
- Ototoxicity (especially with high doses)
|
- Aminoglycosides: Increased risk of ototoxicity.
- NSAIDs: May reduce diuretic efficacy.
- ACE Inhibitors/ARBs: Risk of hypotension and renal impairment.
- Digoxin: Risk of toxicity with hypokalemia.
|
Potassium-Sparing Diuretics (e.g., Spironolactone, Amiloride) |
- Hyperkalemia (high potassium)
- Gynecomastia (with spironolactone)
- Menstrual irregularities (with spironolactone)
- GI disturbances (nausea, vomiting)
|
- ACE Inhibitors/ARBs: Increased risk of hyperkalemia.
- NSAIDs: May increase potassium levels.
- Potassium Supplements: Risk of severe hyperkalemia.
|
Osmotic Diuretics (e.g., Mannitol) |
- Electrolyte imbalance
- Dehydration
- Headache
- Fluid overload (in patients with renal or heart failure)
|
- Nephrotoxic Drugs: Increased risk of renal impairment in patients with compromised kidney function.
|
Carbonic Anhydrase Inhibitors (e.g., Acetazolamide) |
- Metabolic acidosis
- Hypokalemia
- Kidney stones
- Drowsiness and paresthesia
|
- Aspirin (high doses): Can increase acetazolamide toxicity.
- Digoxin: Risk of hypokalemia, may increase toxicity.
- Anticonvulsants: Potential for additive CNS effects.
|